Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“Great opening session and amazing start to an amazing ESMO25! Amazing forward-looking Presidential address, Fabrice Andre, and awesome intro by scientific co-chairs Toni Choueiri, Myriam Chalabi, and amazing award session by Rebecca Dent! Thanks for the shoutout on the NEW TUMOUR AGNOSTIC track.”
Follow the latest ESMO 2025 news on OncoDaily.